Botanical and Plant Derived Drugs Industry to Grow due to Increasing Occurrence of Numerous Chronic Diseases Globally

A new market research report by Transparency Market Research, titled “Botanical and Plant Derived Drugs Market - Global Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 – 2019”, comprises a detailed evaluation of the market. The study presents an examination of the market structure, market drivers, trends, opportunities, and competition within the market in the forecast horizon from 2013 to 2019. It also discusses the size and segmentation of the market throwing light on the top segments and their state by the end of the forecast horizon. The influence of Porter’s five forces on the development of the market also forms a key part of this study.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1864

Botanical drugs are the drugs derived via medicinal plants and are a combination of botanical and other approved drugs that comprise semi-synthetic substances and plant materials. Botanical drugs comprise algae, vegetable materials, and macroscopic fungi. These drugs are utilized for the diagnosis, treatment, cure, and mitigation of numerous diseases such as cardiovascular diseases, central nervous system disorders, respiratory diseases, and infectious diseases. Botanical drugs are an important component of conventional therapies and medicines such as Ayurveda and homeopathy.

As per the report, the rising utilization of botanical drugs in place of synthetic medicine and the increasing occurrence of numerous chronic diseases globally are amongst the prime factors fuelling the growth of the market. Additionally, the decreasing cost of botanical drugs coupled with the technological advancements in their manufacture practices is also a prime factor augmenting the development of the market for botanical and plant derived drugs. On the other hand, according to the report, the strict regulations and laws governing the approval of drugs in a number of nations may inhibit the growth of the market in the coming years. In addition, the low adoption rate of these drugs for the treatment of life threatening diseases will also pose a negative impact on the growth of the market.

In terms of therapeutic application, the report segments the market into infectious diseases, hormone-related disease therapy, pain and central nervous system disorders, respiratory and oncology diseases treatment, and cardiovascular and metabolic diseases.

Geographically, the report segments the market into Asia Pacific, North America, Europe, and Rest of the World (RoW). In Europe, Germany, the UK, and France are the countries dominant in the market for botanical and plant derived drugs. As stated in the report, the major players in the market are Bayer Healthcare, Abbott Laboratories, Bionova, Curapharm, and Bristol Myers, among others.

Future Trends in Tumor Marker Testing Market

Tumor markers are molecules found in urine, blood and body tissues. It is a protein which is found in large amounts in presence of forms of cancer. Thus measuring the levels of tumor markers may help in detecting the presence of cancer.  Presence of a tumor in body stimulates the production of tumor markers from tumor or non-tumor cells.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2253

Tumor marker testing market is categorized on the basis of diagnostic methods, type of cancer and technologies employed for cancer detection:

• Organ specific tumor marker: bladder, breast, colorectal, gastrointestinal, liver, lung, oral, ovarian, pancreatic, prostatic, skin testicular cancer, leukemia, lymphoma, and others

• Clinical laboratory methods for measuring tumor markers: Abbott diagnostics’ AxSYM, Roche Diagnostics System, Fischer Thermo Scientific B.R.A.H.M.S KRYPTOR and others

• New technologies for cancer diagnostics: Monoclonal antibodies, proteomics, new protein markers, stem cell markers, DNA microassays and others

• Clinical methods for cancer diagnosis: Screening, imaging, theranostics, sigmoidoscopy and others

Currently, cancer is the one of the leading causes of death in the developed countries like North America and Europe. North America holds the largest market share in tumor marker testing and is followed by Europe due to vast discoveries and innovations being carried out in these regions for detecting the cancer in its early stages. 

Some of the major factors driving tumor marker testing market are growing incidences of cancer disease, increase in aging population, tremendous ongoing research in the field of cancer detection and improved government reimbursement policies. The key deterrent holding back the market are involvement of high cost.

Some of the major players in tumor marker testing market are Abbott Diagnostics Ltd., Affymetrix, Inc., Agilent Technologies, Inc., Beckman, Dickinson and Company (BD) Diagnostics, BioCurex, BioModa, Inc., Clarient, Inc., Correlogic Systems, Inc., Epigenomics AG, Gen-Probe, Inc., Hologic, Inc., Roche Diagnostics Corp., and Veridex LLC.

Growth of Healthcare/Medical Simulation Market Shifts to High Gear with Rising Demand for Minimally Invasive Treatments

A new market research report by Transparency Market Research, titled “Healthcare/Medical Simulation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018,” presents a detailed analysis of the healthcare/medical simulation market. The information in the study is gathered by conducting both secondary as well as primary research. The data collated in this report is an amalgamation of insights from top industry leaders and historical data. The report also includes a comprehensive review of the market challenges, drivers, impeders, and opportunities. The study encapsulates the key products in the market and their scope in forthcoming years. The use of Porter’s five forces model and SWOT analysis will aid in the business development of the market. An analysis on the competition within the market has enabled calculated decision making by the emerging players looking to invest within this market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1299

Medical simulation is a modern-day method used for the training of healthcare professionals by the utilization of cutting-edge educational technology. It enables experiential learning that is required by every healthcare professional. Medical simulation is also known as simulation in healthcare, healthcare simulation, nursing simulation, patient simulation, clinical simulation, and surgical simulation. It also facilitates the safe training of healthcare learners by engaging in activities that may otherwise be too risky to practice.

As per the institute of medicine, approximately 44,000 to 98,000 deaths take place yearly on a global level owing to medical errors taking place during the treatment of patients. For reducing these errors and for increasing the safety of patients, medical simulation is being extensively utilized worldwide. Hence, as stated in the report, the increasing concern on patient safety coupled with the technological advancements is fuelling the market for medical simulation. In addition, the rising healthcare cost and the rising demand for minimally invasive treatments will also boost the growth of the market. However, the soaring cost of simulators and the lack of funds are the major factors impeding the growth of this market.

Browse Research Report: http://www.transparencymarketresearch.com/healthcare-medical-simulation.html

According to the report, the major services and products in the simulation market are magnetic resonance imaging, computed tomography, live environments, high fidelity mannequins, simulated clinical environment, positron emission tomography, serious game, fidelity trainers, imaging simulation, performance recording, IV simulators, interventional simulators, second life, cardiovascular simulators, ultrasound imaging, mid/low simulator, healthcare/medical simulation training services, and surgical simulators.

Geographically, the report segments the market into Asia Pacific, North America, Europe, and Rest of the World (RoW). Amongst these, North America leads the market for medical simulation and is trailed by Europe and Asia. India and China are poised to emerge as the most lucrative markets in the forthcoming years.

As stated in the report, the prominent players leading the market are LLC, B-Line Medical, 3B Scientific GmbH, Anesoft Corporation, and CAE Ltd., among others.

Global X-ray Market Gains from Rising Prevalence of Diseases, Poised to Touch US$11.79 bn by 2022

The recent commercialization of highly sophisticated X-ray systems and techniques has helped companies enrich their product portfolio and given buyers the ability to invest in more effective products. Moreover, a rapidly aging population, which has caused an increase in the demand for healthcare products and services, will help the X-ray market expand.

Among the key market restraints identified by TMR analysts are: High costs that could hinder widespread adoption and the enforcement of legal provisions that promote healthcare facilities to cut service costs. Market players can benefit from emerging opportunities in countries in Latin America, Africa, and Asia Pacific. The report also conducts a Porter’s five forces analysis to provide clarity on the bargaining power of suppliers and buyers as well as threats posed by substitutes and new market entrants.

The global X-ray market is segmented on the basis of product type, technology, type, applications, and geography. Based on product type, the global X-ray market is segmented into portable and stationary X-rays. Stationary X-ray systems held a sizeable share (60.1%) of the global X-ray market by product type in 2013 as they have been in use since several decades in both mature and developing markets. Over the report’s forecast period, it is expected that portable X-rays will show better growth, more so as portable X-rays find application in home health care.

Likewise, by technology, the report divides the market into digital and analog x-ray. Of these, digital X-ray systems made up the dominant segment with a share of 69.1% in 2013, and were trailed by analog systems in the same year.By type of X-ray, the market segments studied are: photostimulable storage phosphor detectors, flat panel detectors, and others. Similarly, the X-ray market by application is composed of dental X-ray, cardiovascular X-ray, mammography (X-ray), respiratory X-ray, and other applications.

Avail a Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=194

In 2013, North America was the largest X-ray market in the world, with an impressive share of 34.6% in the global market. Asia Pacific and Europe trailed North America. The presence of developed economies such as Canada and the United States in North America has helped the region consolidate its leading position in the global X-ray market. The high geriatric population and rising prevalence of diseases requiring X-rays as part of the diagnostic process have created growth opportunities for market players in this region.

In terms of growth rate, however, Asia Pacific will take the lead and emerge as the fastest-growing region in the global X-ray market. Much of this growth will be made possible by the enormous demand for healthcare from China and India, where people increasingly suffer from numerous diseases.

The report’s Company Profiles section assesses market players such as: Carestream Health, Inc., Shimadzu Corporation, Fujifilm Holdings Corporation, Canon, Inc., Philips Healthcare, Agfa-Gevaert N.V., Konica Minolta, Inc., GE Healthcare, and Hitachi Medical Corporation.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Cardiac Pacemaker Market to Touch US$12.8 bn by 2023, Rising Occurrence of Cardiovascular Diseases to Spur Opportunities in North America

A cardiac pacemaker is a small device placed inside the chest for controlling abnormal heart rhythms. These devices utilize electrical pulses to enable the heart to beat at the normal rate. A slow heartbeat is known as bradycardia, whereas a fast heartbeat is known as tachycardia. Pacemakers are also utilized for recording or monitoring the electrical activity of the heart in addition to improving the heart rhythm.

Pacemakers with advanced technology are even capable of monitoring breathing rates and blood temperatures. Pacemakers can be either permanent or temporary. Temporary pacemakers are utilized for the treatment of short-term heart problems and also in case of emergencies, until the doctor implants a permanent pacemaker. On the other hand, permanent pacemakers are utilized for controlling long-term heart rhythm problems.

The global cardiac pacemaker market is expected to progress from more than US$6 bn in 2014 to US$12.8 bn by 2023 at an 8.70% CAGR. Factors such as a rise in geriatric population, increasing incidence of cardiovascular diseases, and technical advancements are expected to boost the global cardiac pacemaker market in the years to come. However, implementation of the Patient Protection and Affordable Care Act, rising cost of various treatments, and strict regulatory approvals are some of the factors expected to restrict the growth of the global cardiac pacemaker market in the coming few years. The untapped market in the emerging economies is predicted to create growth opportunities for the leading players in the global cardiac pacemaker market during the forecast period.

As stated in the report, the increasing aging population and the rising occurrence of cardiovascular diseases globally are amongst the prime factors stimulating the market for cardiac pacemakers. In addition, a number of technological developments in the market have also augmented the growth of the market. Furthermore, developing economies will present sustainable development opportunities in the market, hence boosting the  growth of the market. On the other hand, the stringent approval process and the soaring costs of treatment are amongst the key factors impeding the growth of the market. In addition, the introduction of the Affordable Healthcare Act has also had a negative impact on the market’s growth.

In terms of product type, the report segments the market into external cardiac pacemakers and implantable cardiac pacemakers. Amongst these, the segment of implantable cardiac pacemakers led the market in 2014 and is predicted to maintain its superiority all through the forecast horizon, expanding at the swiftest growth rate.

Avail a Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=393

On the basis of technology, the report segments the market for cardiac pacemakers into single-chamber pacemakers, dual-chamber pacemakers, and bi-ventricular pacemakers. Amongst these, in 2014, the segment of dual-chamber pacemakers constituted the largest share in the market and is predicted to lead the market throughout the forecast horizon.

In terms of geography, the market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, the North America cardiac pacemakers market led in 2014 and was trailed by the regional market in Europe, which held the second largest share in the market. This is owing to the increasing occurrence of cardiovascular diseases and the high penetration of premium-priced pacemakers within North America. The region of Asia Pacific trailed Europe and stood as the third largest consumer of cardiac pacemakers. This region is poised to exhibit the swiftest CAGR from 2015 to 2023. This is owing to the increasing expansion of market players and enhancement of the healthcare infrastructure within this region.

As mentioned in the report, the prime players operating in the market are Abbott Laboratories, Inc., Boston Scientific Corporation, Cook Medical Inc., SORIN Group., Medtronic, and St. Jude Medical, Inc., among others.

The global Cardiac Pacemakers market is segmented as follows:

Global Cardiac Pacemakers Market, by Product Type

• Implantable Cardiac Pacemaker
• External Cardiac Pacemaker

 Global Implantable Cardiac Pacemakers Market, by Technology

• Dual-Pacemaker
• Single-Chamber
• Bi-Ventricular

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Technical Progression to Boost Latin American Minimally Invasive Surgery Market Growth

The Latin America minimally invasive surgery market is expected to progress at a CAGR of 10.80% between 2014 and 2020. The market was valued at US$925 mn in 2013 and is expected to reach US$1.93 bn by the end of 2020, as mentioned in a research report released by Transparency Market Research, titled “Latin America Minimally Invasive Surgery Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”.According to the report, the primary growth driver of the Latin America minimally invasive surgery market is the large-scale use of advanced surgical instruments in the recent years. This market provides the benefit of performing low-cost surgeries, adding to its rate of preference.

The increase in preference of minimally invasive surgeries in Latin America is also attributed to the higher rate of patient comfort in terms of surgical discomfort and reduction in duration of their hospital stay.The report segments the Latin America minimally invasive surgery market according to the categories of product types, type of surgery, and country. From the point of view of product types, the Latin America minimally invasive surgery market was dominated by surgical devices in 2013. This is attributed directly to the growing use of advanced surgical tools that reduce the need for invasive surgery. The fastest growth rate in the product segment is attributed to medical robots.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3842

In terms of types of surgeries, the Latin America minimally invasive surgery market was led by cardiac surgery in 2013 according to revenue. However, the report states that this segment is expected to decline in market share owing to the rapid rate of increase of cosmetic surgeries in Brazil and Mexico. The segments of orthopedic and cosmetic surgeries are expected to witness the fastest rate of growth within the report’s forecast period.

Regionally, the Latin America minimally invasive surgery market was led by Brazil and Mexico as the two nations collectively held over 50% of the market in 2013. Mexico is expected to show the fastest growth rate within the report’s forecast period, followed closely by Brazil.The report cites figures by the International Society of Aesthetic Plastic Surgery, which states that there was a 120% increase in the number of cosmetic surgeries in Brazil between 2009 and 2012. This favors the Latin America minimally invasive surgery market to a large extent. 

Key players in the Latin America minimally invasive surgery market are Stryker Corporation, Abbott Laboratories, Inc., Varian Medical Systems, Inc., Siemens Healthcare, GE Healthcare, Medtronic, Inc., Teleflex, Covidien plc, DePuy Synthes, Inc., Biomet, Inc., and Philips Healthcare. The top companies of the Latin America minimally invasive surgery market all possess highly advanced product portfolios which allow them to take up larger share in the market.

Global ePharmacy Market Flourishing in Western World, Asia Pacific Offers Strong Growth Opportunities

Epharmacies are online platforms where consumers can buy various medicines. The ecommerce model utilized in Epharmacies means that consumers can purchase medicines without having to go brick-and-mortar pharmacies, as the online vendor will deliver medicines at the consumer’s doorstep. This makes the process more convenient for consumers, which has resulted in rising demand for the model across the world.

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=397

Increasing Use of Healthcare IT to Propel Global ePharmacy Market to US$128 bn by 2023

The growing incorporation of e-prescriptions due to the increasing utilization of healthcare IT in hospitals worldwide has also helped the spread of the ePharmacy industry, since e-prescriptions can simply be uploaded to ePharmacy websites, which can then procure the items in the prescription automatically.

According to Transparency Market Research, the global ePharmacy market was worth US$29.3 bn in 2014, indicating the rapid progress the market has made in the relatively short time since ecommerce became a commonly accessible tool. The market is expected to exhibit a sturdy 17.7% CAGR from 2015 to 2023 and reach a valuation of US$128 bn.

Europe to Dominate Global ePharmacy Market…

Regionally, the global ePharmacy market is led by North America and Europe; the former held a dominant 37% share in the global market in 2014. The easy incorporation of technologically advanced healthcare solutions such as ePharmacy platforms into the existing healthcare platforms in these regions has helped these regional markets. Europe is expected to take the lead in the global market in the coming years in terms of revenue generation.

… but APAC Emerges as a Greener Pasture for the Future

However, the major opportunity for the global ePharmacy market lies in the vast unmet needs in the developing Asia Pacific market. The China market for ePharmacy, in particular, carries vast potential for usage of ePharmacy platforms. According to a report released last month by the Boston Consulting Group, the China ePharmacy market was worth US$1.1 bn in 2014, rising rapidly since its early inroads around the turn of the decade. Government intervention in China has helped the ePharmacy industry massively, with the demand to reduce the reliance on hospitals for sales of medicines leading to a major growth opportunity for online pharmacies, particularly if the government allows the sale of prescription drugs via online portals.

India is also an emerging ePharmacy market with significant promise for the near future. Due to the large population of India, second only to China, the number of people with unmet medical needs is quite high. And with penetration of the Internet rising in urban as well as rural parts of India, the timing is perfect for ePharmacy market players to carve out a foothold. 1mg, an ePharmacy startup allowing consumers to not only purchase medicine online but also look up information and cheaper alternatives, recently announced a US$15-million series B funding round. Led by Maverick Capital Ventures and including previous backers such as Omidyar Ventures and Sequoia Capital, the round brought 1mg’s total funding to US$21 mn.

Browse Research Release: 

http://www.transparencymarketresearch.com/pressrelease/global-epharmacies-market.htm

With government support in Asia Pacific rising at a promising rate and Europe expected to carry on supporting the spread of ePharmacies, the global ePharmacy market is expected to grow by leaps and bounds in the coming years.

Increasing Array of Products to Enable Growth of Global Contact Lenses Market as it Reaches US$13.47 bn by 2019

Contact lenses use hydrogel or silicon hydrogel shaped to fit right above the cornea and help eliminate or reduce vision impairments that a patient suffers from. These could include glaucoma, presbyopia, astigmatism, and myopia. At the same time, contact lenses can also be used to change the way the consumer’s eyes appear. People may use lenses to change the color as well as the appearance of the eye. In terms of function, contact lenses are becoming highly durable and provide state-of-the-art scratch resistance and comfort.

The major factors that are increasing the demand for lenses are the higher number of patients with ophthalmologic disorders. According to the National Eye Association of the U.S., at least 11 mn of American consumers were suffering from eye related problems including hyperopia and astigmatism. The number of people with vision problems is increasing due to negative changes in lifestyles and an increasing percentage of the geriatric demographic.

The report divides the global contact lenses market in terms of characteristics, designs, usage, and geography.

According to usage pattern, the global contact lens market is spearheaded by the segment of corrective lenses. This segment is progressing at a CAGR of 12.2% within the report’s given forecast period.

In terms of design, the segment of multifocal lenses is the fastest growing one for the forecast period. It was valued at US$553.7 mn in 2012 and its growth rate is attributed to the high number of people suffering from myopia in the world.

North America was the dominant region in the global contact lenses market in 2012, when it accounted for 42% of the market. This massive market for contact lenses in North America is also corroborated by the CDC, which had stated that nearly 11 mn American citizens older than 12 years can negate their vision issues by using refractive correction.

At the same time, Asia Pacific is showing the fastest growth rate in the global contact lenses market, owing to a high population density and a large untapped market that is drawing the attention of top global players. A larger percentage of the population in developing economies can now afford premium and semi-premium branded contact lenses due to higher disposable incomes.

Get Free Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1787

The key players in the global contact lenses market are SynergEyes, Inc., STAAR Surgical Company, Johnson & Johnson, Hoya Corporation, Essilor International, CooperVision, Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Alcon Laboratories, Inc., and Abbott Medical Optics, Inc.

Key segments of the Global Contact Lenses Market

Contact Lens Market, by Characteristics

• Spherical Contact Lens
• Toric Contact Lens
• Gas-Permeable Contact Lens
• Soft Contact Lens
  
  • Daily Disposable
  • Weekly Replacement
  • Monthly Replacement
  • Extended Wear
  • Annual Replacement
  • Unplanned Replacement Schedule

Contact Lens Market, by Design

• Spherical Contact Lens
• Toric Contact Lens
• Multifocal Contact Lens
• Orthokeratology Contact Lens

Contact Lens Market, by Usage

• Corrective Contact Lens
• Therapeutic Contact Lens
• Post-Operative Therapeutic Contact Lens
• Cosmetic Contact Lens
• Enhancement Tints
• Opaque and Special Effect Contact Lens
• Prosthetic Contact Lens
• Computer Lens
• D-Segment Contact Lens
• Sports Lens
• Custom-made Contact Lens

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Wearable Medical Devices: Demand for Activity Monitors to Surge in Coming Years

Wearable technology has gained momentum in the past few years. Changing lifestyle of young people demands connectivity. The health care segment accounts for a major share of the wearable technology market, considering the innovations in several applications in this area in the last two decades. While a smartphone remains the choice of the global population, the tech world is constructing a future of wearable devices that promises consumers to help them live healthier lives, Mobile phones having wearable sensors embedded in it, and implanted medical devices can help monitor and manage the health. Technology companies interested in health and wellness have introduced various products in the wearable medical devices market including bands, wristwatches, chest and straps that are user-friendly, compact, and noninvasive. In 2013, Google Inc. introduced Google Glass, an eyewear that is highly dynamic. It can be used in various applications across industries. Technology has proven to be a boon for the medical community.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1733

A wearable medical device is an autonomous, non-invasive device that accomplishes medical functions such as monitoring and support over an extended period. The term wearable indicates that the support environment is either clothing or human body. These devices help to monitor activity and sleep patterns. Some of the wearable medical devices also help to detect body temperature, hydration level, heart rate, etc. Wearable medical devices, therefore, help in managing the treatment of chronic diseases such as asthma, heart diseases, and diabetes. The data produced by these devices is frequently supported with analytics. This information can be used by health care organizations to improve care and potentially decrease the cost. 

High Cost of Wearable Medical Devices to Restrain Growth of Global Wearable Medical Devices Market

The growing prevalence of diabetes has fuelled the need to monitor blood glucose level as well as other vital signs among patients. This has boosted the demand for wearable medical devices. The ease of use and interpretation of wearable medical devices, increasing per capita income, and the rise in adoption of wearable medical devices are some of the key factors propelling the growth of the global wearable medical devices market. However, the high cost of these devices will restrain the growth of the market, especially across the emerging economies. The overall market has a huge opportunity to grow with the increasing diabetic population in Asia Pacific.

Demand for Activity Monitors to Surge in Coming Years

On the basis of product type, the global wearable medical devices market has been broadly divided into wearable diagnostic medical devices and wearable therapeutic medical devices. Wearable diagnostic medical devices have been further categorized into fetal and obstetric devices, vital signs monitor, and neuromonitoring devices. The wearable therapeutic medical devices segment has been further divided into glucose/insulin monitoring, pain management, and respiratory therapy devices. In 2012, heart rate monitors dominated the overall wearable medical devices market. Heart rate monitors were the first wearable medical devices to be made available commercially. In the near future, the demand for activity monitors is expected to surge significantly.

On the basis of application, the global wearable medical devices market is segmented into remote patient monitoring, sports and fitness, and home healthcare. While the demand from the home healthcare application segment is rising due to the growing number of chronically ill patients, the overall market is expected to be propelled by the increasing usage of wearable medical devices in sports and fitness.

Growing Demand from Asia Pacific to Drive Global Wearable Medical Devices Market

The global wearable medical devices market can be segmented into four key regions: Europe, North America, Asia Pacific, and Rest of the World. In 2012, North America dominated the overall market with 44% share. The region’s dominance in the market can be attributed to the growing demand for wearable heart rate monitors, coupled with rapid technological advancements. However, in the coming years, Asia Pacific is anticipated to register the fastest growth in the market owing to the growing demand for wearable medical devices across emerging economies such as India and China. The region is projected to expand at a CAGR of over 18% during the period between 2013 and 2019. However, the market is yet to tap the full potential of research and development activities across the region.

Key Players in Global Wearable Medical Devices Market

Some of the key players in the global wearable medical devices market are Corventis Inc., Basis Science Inc., Everist Genomics Inc., Draeger, Intelesens Ltd., Fitbit Inc., Nuubo, LifeWatch AG, Philips Electronics, Omron Corporation, Sotera Wireless, Polar Electro, Zephyr Technology Corporation, and Withings. 

Global DNA Chip Market Boosted by Growth in Personalized Medicine

A DNA chip, also known as a DNA microarray, is similar to a computer chip. The major difference between the two is that a computer chip is embedded with electric circuitry, whereas a DNA chip or a DNA microarray is embedded with DNA molecules. A DNA chip comprises a group of DNA spots that are primarily embedded on a solid surface. A DNA gene chip is the size of a postage stamp and this technology is popularly used for drug discovery in the medical research sector. A DNA microarray plays an important role in assisting medical professionals and researchers in simultaneously measuring the levels of expression of thousands of genes.

The popularity of DNA chips has encouraged many new companies or players to enter the global DNA chip market. Considering all these factors, the global DNA chip market is expected to register double-digit growth during the period from 2015 to 2023. The growth in personalized medicines and large-scale initiatives taken by the governments of many nations to promote DNA chip technology are predicted to propel the global DNA chip market in the coming few years.

By type, the global DNA chip market is classified into oDNA (oligonucleotide DNA) and cDNA (complementary DNA), the former being the dominant segment and accounting for more than 95% of the global DNA chip market. Based on application, the global DNA chip market is classified into comparative genomic hybridization, geneID, gene expression, and others. Currently, the global DNA chip market is dominated by the gene expression segment. This segment is expected to maintain its dominance in the years to come due to increasing funding from the governments of various nations. Contribution from many private players is expected to further propel the gene expression segment in the years to come. 

By region, the global DNA chip market is divided into Asia Pacific, Europe, North America, and Rest of the World. Currently, North America dominates the global DNA chip market. However, the Asia Pacific DNA chip market is expected to register aggressive growth in the next few years. 

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4310

Factors that add value to the global DNA chip market are a strong supply chain, availability of cutting-edge infrastructure, world-class logistical connectivity, and easy availability of a skilled workforce. As per the World Health Organization (WHO), in 2012, globally around 8.2 million people died due to cancer. As per the American Cancer Society (ACS), in 2012, around 300,000 men and around 276,000 women died because of cancer in the United States. The high occurrence of cancer in the region is expected to propel the global DNA chip market in the years to come.

Some of the leading players in the global DNA chip market are Affymetrix, Inc., Biomérieux Sa., Capitalbio Corporation, Eurofins Mwg Operon, Greiner Bio-One, Life Technologies Corporation, Macrogen Inc, Scienion Ag, Savyon Diagnostics Ltd, and Wafergen Biosystems Inc.

  

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Collagen Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023

Collagen represents one of the most profuse protein present in the animals and has been subjected to rigorous research activities. This has increased the use of collagen across various industries. It is extracted from various land animals (mainly bovine & porcine) and birds. This resulted in identification of alternative sources of collagen such as marine sources. Collagen is found in the connective tissue of a human body. Individuals suffering from osteoarthritis and rheumatoid arthritis are often prescribed collagen supplements to replace the collagen in the joints. Three major types of collagen are widely used in various applications: Type I, Type II, and Type III. Their use is specific to certain body parts.

Marine collagen is a preferred source over conventional sources owing to properties such as low molecular weight, high absorption, and excellent bioavailability. In addition, low risk of disease transfer and negligible religious barriers on the use of marine collagen will support the uptake of this source during the forecast period. Factors such as increasing commercialization of novel collagen sources and rigorous research and development in the field of regenerative medicine and wound healing will propel market growth.

On the other hand, high risk of disease transmission and undesirable influence of religious beliefs and culture toward consumption or use of collagen-based products are likely to hamper market growth. However, increasing preference for minimally or non-invasive technologies and rising demand for novel and synthetic collagen sources are anticipated to provide lucrative opportunities in the market.

The bovine and porcine collagen segments accounted for over 60% of the collagen market in 2014 as these sources are considered to be primitive sources and provide high yield coupled with low cost. However, demand for these sources is expected to decline during the forecast period from 2015 to 2023 due to high risk of disease transmission and rising negative influence of religious beliefs and culture. In terms of volume, the marine collagen products segment is anticipated to record the highest growth rates as compared to bovine and porcine collagen consumption.

Chicken, ovine, equine, silkworm, and rat tail are some of the other sources of collagen on which a lot of research and development is carried out currently. Chicken collagen is majorly used for supporting the cartilage of the body and hence type II collagen is majorly derived from chicken. However, this type of collagen is least preferred in medical applications as it causes allergic reactions and is ineffective in raising the overall levels of collagen in the body.

Demand for other collagen sources such as equine, ovine, and rat tail is expected to increase during the forecast period due to increasing research efforts by the market players toward standardizing the alternative sources of collagen. Currently, there are few products extracted from these sources and many are still in the research phase. Hence, the other collagen sources market is likely to be small in terms of both revenue and volume during the forecast period.

Get Free Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10460

The market for the collagen based applications is expected to record considerable growth rate owing to increasing use of collagen based products in pharmaceuticals and medical devices. Extensive use of collagen in tissue engineering and drug delivery applications is due to benefits of collagen in wound healing and bone graft substitutes. Companies such as Medtronic plc, Kyeron B.V., Collagen Solutions plc, and botiss biomaterials GmbH are the key players offering collagen-based bone and dental grafts. Rising demand for novel drug delivery systems in ophthalmology, wound healing, and other therapeutic areas is likely to increase the uptake and acceptance of collagen-based products.

The collagen market is consolidated, with a few companies accounting for major market share. Several new entrants are looking forward to merge or collaborate with the large companies to facilitate the production of specified grade of collagen or manufacture of specific collagen-based medical devices. This would enable the large companies to scale up their operations and expand their product offerings with high efficiency. Furthermore, increasing collaboration of collagen manufacturers with pharmaceutical and biotechnology companies is likely to support market growth during the forecast period. Collagen Solutions, plc, Collagen Matrix, Inc., Nippi, Inc. Medtronic plc, and Baotou Dongbao Bio-Tech Co. Ltd are the key players operating in the collagen market.

The global collagen market is segmented into the following categories:

Global Collagen Market, by Source

• Bovine
• Porcine
• Chicken
• Marine
• Others

Global Collagen Market, by Application

• Drug Delivery Systems
  
  • Collagen Shields
  • Collagen Sponges
  • Sustained Drug Delivery Systems
  • Transdermal Patches
  • Other Drug Delivery Systems
• Tissue Engineering
  
  • Skin replacement
  • Bone Substitutes
  • Others

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.